Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

The Report Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -


Albany, NY -- (SBWIRE) -- 11/28/2014 -- This report on cancer diagnostics analyzes the current as well as future prospects of various facets of the market in detail. It provides an in-depth and comprehensive analysis of the cancer diagnostics market. The report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study for various segments such as diagnostic methods, applications, and geography (North America, Europe, Asia-Pacific and Rest of the World).

View Full Report at

For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within cancer diagnostics market, which was supplemented by extensive secondary research. The report provides market size in terms of USD million for each segment for the period 2012 to 2020, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall cancer diagnostics market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. Growth rates for each segment within the cancer diagnostics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Download Detail Report With Complete TOC at

The global cancer diagnostics market is categorized based on the diagnostic methods into four major segments, namely, tumor biomarker tests, imaging, endoscopy, and biopsy. The market analysis provided for tumor biomarker tests include revenue from major cancer biomarker tests such as prostate specific antigen (PSA) tests, human epidermal growth factor receptor 2 (HER2) tests, circulating tumor cells (CTC) tests , carcinoembryonic antigen (CEA) test, anaplastic lymphoma kinase (ALK) test, BRCA gene tests, and other tests such as AFP, CA 19-9, CA 125 tests. The report also provides market size for imaging procedures for cancer diagnostics, namely, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), x-ray and ultrasound imaging. The market size estimation for endoscopies such as colonoscopy, sigmoidoscopy, bronchoscpopy and colposcopy; and biopsies such as bone marrow biopsy, needle biopsy and endoscopic biopsy are provided in the report.

Explore All Latest Published Reports By Transparency Market Research at

The cancer diagnostics market has been further analyzed for applications such as cancer of lung, breast, colorectal, prostate, liver, blood, and others (cancers of kidney, pancreas, and ovary). According to our estimates, in 2013, lung cancer accounted for the largest share in the global cancer diagnostics market and is expected to continue to grow in the near future. On the basis of geography, the overall global cancer diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The research study also incorporates a qualitative analysis of the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the cancer diagnostics market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter's five forces analysis. In addition, the study also provides insights into the competitive landscape of the global cancer diagnostics market.

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The report also profiles major players in the cancer diagnostics market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players covered in this report are Abbott Laboratories, Ambry Genetics, AstraZeneca plc, bioMerieux SA, Eli Lilly and Company, Genoptix (A Novartis Company), GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd. and Pfizer, Inc.

The global cancer diagnostics market is segmented as follows:

Cancer Diagnostics Market, by Method

Tumor Biomarker Tests

PSA Tests
CTC Tests
AFP Tests
CA 19-9
CA 125


MRI Scan
PET Scan
CT Scan


Bone Marrow Biopsy
Needle Biopsy
Endoscopic Biopsy

Cancer Diagnostics Market, by Application

Breast Cancer
Colorectal Cancer

Cancer Diagnostics Market, by Geography

North America
Rest of the World

Related Reports

Global and China Anesthesia Machine Industry 2014 Deep Research Report

View Full Report at

The report firstly introduced Anesthesia Machine basic information included Anesthesia Machine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Korea etc regions) Global Leading Suppliers, different type products, different applications etc Anesthesia Machine production and market share, Anesthesia Machine industry policy and plan, Anesthesia Machine product specification, manufacturing process, product cost structure etc.

Download Detail Report With Complete TOC at

Then statistics Global key manufacturers Anesthesia Machine capacity production cost price profit production value Gross Margin etc details information, at the same time, statistics these manufacturers Anesthesia Machine products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global Anesthesia Machine capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced Global Anesthesia Machine 2009-2019 capacity production price cost profit production value Gross Margin etc information.

Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific

View Full Report at

GBI Research's report, "Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Asia-Pacific" provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices.

Download Detail Report With Complete TOC at

The analysis includes market size data by revenue and volume over the 2006 2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog at